Earnings History Data for Harpoon Therapeutics (HARP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Harpoon Therapeutics

Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company developing a novel class of T cell engagers which harness the power of the body's immune system to treat patients suffering from cancer and other diseases. Using its proprietary Tri-specific T cell Activating Construct(TM) platform, they are developing a pipeline of novel T cell engagers, focused on the treatment of solid tumors and hematologic malignancies. Harpoon Therapeutics Inc. is based in San Francisco, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-11-2023	AH		HARP	Harpoon Therapeutics	24.00	-0.46	-3.09	0.00	Harpoon Therapeutics GAAP EPS of -$0.46, revenue of $4.54M [11/10/2023 10:46 AM]	6.32	-0.02 (-0.32%)	0.0	0.0 (0.00%)	3.11 - 33.55	134,769	110,000	0
Harpoon Therapeutics GAAP EPS of -$0.46, revenue of $4.54M [11/10/2023 10:46 AM]
27-03-2023	AH	4:00 PM ET (Mar 27)	HARP	Harpoon Therapeutics	23.00	-0.55	-0.43	0.00	Harpoon Therapeutics GAAP EPS of -$0.55 misses by $0.08, revenue of $4.1M misses by $2.94M [3/27/2023 5:13 PM]	0.6725	0.02 (2.99%)	0.66	0.0 (0.31%)	0.59 - 5.16	317,721	340,000	5,201
Harpoon Therapeutics GAAP EPS of -$0.55 misses by $0.08, revenue of $4.1M misses by $2.94M [3/27/2023 5:13 PM]
14-11-2022	PM		HARP	Harpoon Therapeutics	25.00	-0.35	-0.60	0.00	Harpoon Therapeutics GAAP EPS of -$0.35 beats by $0.20, revenue of $13.6M beats by $7.25M [11/15/2022 4:49 AM]	0.8218	0.03 (4.00%)	0.81	0.02 (2.51%)	0.70 - 8.20	141,963	180,000	12,333
Harpoon Therapeutics GAAP EPS of -$0.35 beats by $0.20, revenue of $13.6M beats by $7.25M [11/15/2022 4:49 AM] Harpoon Therapeutics, Inc. (HARP) Reports Q3 Loss, Tops Revenue Estimates [Nov-14-22 05:25PM] Harpoon Therapeutics Updates Strategic Priorities and Reports Third Quarter 2022 Financial Results [Nov-14-22 04:01PM]
10-08-2022	AH		HARP	Harpoon Therapeutics	71.00	-0.53	-0.55	0.00	Harpoon Therapeutics GAAP EPS of -$0.53 beats by $0.03, revenue of $8.3M beats by $1.34M [8/10/2022 4:50 PM]	2.01	-0.15 (-6.94%)	2.30	0.14 (6.48%)	1.73 - 9.94	228,794	130,000	1,125
Harpoon Therapeutics GAAP EPS of -$0.53 beats by $0.03, revenue of $8.3M beats by $1.34M [8/10/2022 4:50 PM] Harpoon Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update [Aug-10-22 04:01PM] Shareholders in Harpoon Therapeutics (NASDAQ:HARP) are in the red if they invested three years ago [Aug-10-22 07:32AM]
10-03-2022	AH	4:05 PM ET (Mar 10)	HARP	Harpoon Therapeutics, Inc.	148.68	-0.66	-0.46	-0.45	Harpoon Therapeutics GAAP EPS of -$0.66 misses by $0.23, revenue of $4.3M misses by $1.9M [3/10/2022 6:12 PM]	3.94	-1.47 (-27.17%)	5.15	-0.26 (-4.81%)	3.30 - 24.20	1,368,108	830,000	5,792
Harpoon Therapeutics GAAP EPS of -$0.66 misses by $0.23, revenue of $4.3M misses by $1.9M [3/10/2022 6:12 PM] Harpoon crashes on plans to halt prostate cancer study [3/11/2022 1:45 PM] Invacare (IVC) Q4 Earnings Top Estimates [Mar-08-22 06:55PM] Harpoon Therapeutics, Inc. (HARP) Reports Q4 Loss, Lags Revenue Estimates [Mar-10-22 05:45PM] Harpoon Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update [Mar-10-22 04:04PM] Harpoon Therapeutics Discontinues Its Once Lead Prostate Cancer Candidate [Mar-11-22 10:53AM]
05-08-2021	AH	4:00 PM ET (Aug 5)	HARP	Harpoon Therapeutics, Inc.	334.02	-0.52	-0.45	-0.51	Harpoon Therapeutics EPS misses by $0.09, misses on revenue [8/5/2021 5:27 PM]	9.44	-0.45 (-4.55%)	9.90	0.01 (0.10%)	9.14 - 25.23	634,212	800,000	7,264
Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences [Aug-03-21 04:05PM] Harpoon Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-05-21 04:05PM] Harpoon Therapeutics, Inc. (HARP) Reports Q2 Loss, Lags Revenue Estimates [Aug-05-21 06:55PM]
06-05-2021	AH		HARP	Harpoon Therapeutics, Inc.	733.78	-0.37	-0.43	-0.51	Harpoon Therapeutics EPS misses by $1.50, beats on revenue [5/6/2021 5:08 PM]	22.42	0.38 (1.72%)	22.50	0.0 (0.00%)	10.55 - 25.23	269,490	220,000	167
Harpoon Therapeutics EPS misses by $1.50, beats on revenue [5/6/2021 5:08 PM] Harpoon Therapeutics, Inc. (HARP) Reports Q1 Loss, Tops Revenue Estimates [May-06-21 05:55PM] Harpoon Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-06-21 04:04PM]
10-03-2021	AH	4:05 PM ET (Mar 10)	HARP	Harpoon Therapeutics, Inc.	584.21	-0.45	-0.57	-0.58	Harpoon Therapeutics EPS beats by $0.11, beats on revenue [3/10/2021 4:26 PM]	19.75	-0.34 (-1.69%)	20.48	0.39 (1.94%)	10.27 - 25.24	320,810	259,259	550
Harpoon Therapeutics EPS beats by $0.11, beats on revenue [3/10/2021 4:26 PM] Harpoon Therapeutics to Participate in 33rd Annual Roth Conference [Mar-09-21 07:30AM] Harpoon Therapeutics, Inc. to Host Earnings Call [Mar-10-21 01:30PM] Harpoon Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update [Mar-10-21 04:05PM] Harpoon Therapeutics, Inc. (HARP) Reports Q4 Loss, Tops Revenue Estimates [Mar-10-21 05:25PM] Harpoon Therapeutics Announces Poster Presentations and Publication of Abstracts for AACR Annual Meeting 2021 [Mar-11-21 01:16PM]
04-11-2020	AH		HARP	Harpoon Therapeutics, Inc.	374.11	-0.53	-0.55	-0.65	Harpoon Therapeutics EPS in-line, misses on revenue [11/4/2020 5:04 PM]	16.58	0.55 (3.43%)	16.03	0.0 (0.00%)	10.27 - 25.02	103,452	71,378	204